Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 3/20 | 0.51 |
| ▸ | DRD1 | P21728 | 2/20 | 0.36 |
| ▸ | PRCP | P42785 | 2/20 | 0.34 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL242551 | 0.82 | TOP1 (0.43) | TOP1CYP11B2CYP3A4 | |
| SCHEMBL238687 | 0.81 | TOP1 (0.38) | TOP1DRD1CYP3A4TDP1 | |
| SCHEMBL19511368 | 0.78 | ESR1 (0.41) | PRCPNOS1ESR1ESR2CYP11B2 | |
| SCHEMBL29556500 | 0.77 | TOP1 (0.36) | TOP1GRIN2BSIGMAR1 | |
| SCHEMBL30124970 | 0.70 | ESR1 (0.51) | PRCPESR1ESR2CYP11B2GRIN2B | |
| SCHEMBL5051433 | 0.70 | ESR1 (0.51) | PRCPESR1ESR2CYP11B2GRIN2B | |
| SCHEMBL13306192 | 0.70 | ESR1 (0.51) | PRCPESR1ESR2CYP11B2GRIN2B | |
| SCHEMBL13784817 | 0.70 | ESR1 (0.51) | PRCPESR1ESR2CYP11B2GRIN2B | |
| SCHEMBL241233 | 0.69 | NPSR1 (0.34) | PRCPNOS1ESR1ESR2CYP11B2 | |
| Hydrochloric Acid SCHEMBL30542604 | 0.68 | ESR1 (0.50) | PRCPESR1ESR2CYP11B2GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2076524-B1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2016-04-20 | — | — | EP | disclosed |
| EP-2076524-B1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2016-04-20 | — | — | EP | disclosed |
| US-8735583-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) | 2014-05-27 | — | — | US | disclosed |
| US-8735583-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) | 2014-05-27 | — | — | US | disclosed |
| US-8735583-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) | 2014-05-27 | — | — | US | disclosed |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-06-13 | — | — | US | disclosed |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-06-13 | — | — | US | disclosed |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-06-13 | — | — | US | disclosed |
| US-8404843-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-03-26 | — | — | US | disclosed |
| US-8404843-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-03-26 | — | — | US | disclosed |
| US-8222415-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-07-17 | — | — | US | disclosed |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2010-09-23 | — | — | US | disclosed |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2010-09-23 | — | — | US | disclosed |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2010-09-23 | — | — | US | disclosed |
| EP-2076524-A1 | CHIRAL PHOSPHORUS COMPOUND | Johnson Matthey Public Limited Company (GB) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008041029-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2008-04-10 | — | — | WO | disclosed |
| WO-2008041029-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2008-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | PIK3CA, RECQL, P2RY1 | TOP1 528/4885DRD1 2720/4885PRCP 2065/4885 |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | PIK3CA, RECQL, P2RY1 | TOP1 528/4885DRD1 2720/4885PRCP 2065/4885 |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | ALPP, PTH1R, CALCR | TOP1 1602/4885DRD1 3542/4885PRCP 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.